TELA Bio Inc (TELA)
4.63
0.00 (0.00%)
USD |
NASDAQ |
May 02, 16:00
4.64
+0.01
(+0.22%)
Pre-Market: 20:00
TELA Bio Cash from Financing (TTM): 46.27M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 46.27M |
September 30, 2023 | 46.03M |
June 30, 2023 | 80.52M |
March 31, 2023 | 40.76M |
December 31, 2022 | 40.85M |
September 30, 2022 | 41.24M |
June 30, 2022 | 6.935M |
March 31, 2022 | 0.403M |
December 31, 2021 | 0.585M |
Date | Value |
---|---|
September 30, 2021 | 0.457M |
June 30, 2021 | -0.081M |
March 31, 2021 | 44.96M |
December 31, 2020 | 44.41M |
September 30, 2020 | 95.47M |
June 30, 2020 | 98.01M |
March 31, 2020 | 64.53M |
December 31, 2019 | 65.53M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-0.081M
Minimum
Jun 2021
98.01M
Maximum
Jun 2020
42.17M
Average
44.41M
Median
Dec 2020
Cash from Financing (TTM) Benchmarks
Cutera Inc | -2.568M |
Dynatronics Corp | 1.604M |
Stereotaxis Inc | 0.081M |
Electromed Inc | -0.128M |
Myomo Inc | 9.714M |